Hyperglycemic kidney damage in an animal model of prolonged critical illness.

[1]  M. Siegel,et al.  Glucose control in the ICU--how tight is too tight? , 2009, The New England journal of medicine.

[2]  G. Van den Berghe,et al.  Intensive insulin therapy in the intensive care unit , 2009, Canadian Medical Association Journal.

[3]  Deborah J. Cook,et al.  Intensive insulin therapy and mortality among critically ill patients: a meta-analysis including NICE-SUGAR study data , 2009, Canadian Medical Association Journal.

[4]  Stephane Heritier,et al.  Intensive versus conventional glucose control in critically ill patients. , 2009, The New England journal of medicine.

[5]  L. Foubert,et al.  Tight perioperative glucose control is associated with a reduction in renal impairment and renal failure in non-diabetic cardiac surgical patients , 2008, Critical care.

[6]  Renda Soylemez Wiener,et al.  Ill Adults: A Meta-analysis Benefits and Risks of Tight Glucose Control in Critically , 2010 .

[7]  G. Van den Berghe,et al.  Tight blood glucose control is renoprotective in critically ill patients. , 2008, Journal of the American Society of Nephrology : JASN.

[8]  Stephen Daniel,et al.  Intensive insulin therapy and mortality in critically ill patients , 2008, Critical care.

[9]  Rolf Rossaint,et al.  Intensive insulin therapy and pentastarch resuscitation in severe sepsis. , 2008, The New England journal of medicine.

[10]  G. Van den Berghe,et al.  Effect of intensive insulin therapy on insulin sensitivity in the critically ill. , 2007, The Journal of clinical endocrinology and metabolism.

[11]  G. Van den Berghe,et al.  Tight blood glucose control with insulin in the ICU: facts and controversies. , 2007, Chest.

[12]  R. Unwin,et al.  The Not So ‘Mighty Chondrion’: Emergence of Renal Diseases due to Mitochondrial Dysfunction , 2006, Nephron Physiology.

[13]  Miet Schetz,et al.  Intensive Insulin Therapy in Mixed Medical/Surgical Intensive Care Units , 2006, Diabetes.

[14]  P. O’Connor.  RENAL OXYGEN DELIVERY: MATCHING DELIVERY TO METABOLIC DEMAND , 2006, Clinical and experimental pharmacology & physiology.

[15]  Paul J Thornalley,et al.  Increased Dicarbonyl Metabolism in Endothelial Cells in Hyperglycemia Induces Anoikis and Impairs Angiogenesis by RGD and GFOGER Motif Modification , 2006, Diabetes.

[16]  P. Devarajan.  Update on mechanisms of ischemic acute kidney injury. , 2006, Journal of the American Society of Nephrology : JASN.

[17]  Gilles Clermont,et al.  RIFLE criteria for acute kidney injury are associated with hospital mortality in critically ill patients: a cohort analysis , 2006, Critical care.

[18]  G. Van den Berghe,et al.  Intensive insulin therapy in the medical ICU. , 2006, The New England journal of medicine.

[19]  G. Van den Berghe,et al.  Survival benefits of intensive insulin therapy in critical illness: impact of maintaining normoglycemia versus glycemia-independent actions of insulin. , 2006, Diabetes.

[20]  J. Kellum,et al.  Primary prevention of acute renal failure in the critically ill , 2005, Current opinion in critical care.

[21]  John A Kellum,et al.  Risk factors for acute renal failure: inherent and modifiable risks , 2005, Current opinion in critical care.

[22]  J. Revelly,et al.  Lactate and glucose metabolism in severe sepsis and cardiogenic shock* , 2005, Critical care medicine.

[23]  John A Kellum,et al.  Acute renal failure in critically ill patients: a multinational, multicenter study. , 2005, JAMA.

[24]  Ilse Vanhorebeek,et al.  Intensive insulin therapy protects the endothelium of critically ill patients. , 2005, The Journal of clinical investigation.

[25]  V. Monnier,et al.  Glycation of mitochondrial proteins from diabetic rat kidney is associated with excess superoxide formation. , 2005, American journal of physiology. Renal physiology.

[26]  Paul J Thornalley,et al.  Methylglyoxal administration induces diabetes-like microvascular changes and perturbs the healing process of cutaneous wounds. , 2005, Clinical science.

[27]  Paul J Thornalley.  Dicarbonyl Intermediates in the Maillard Reaction , 2005, Annals of the New York Academy of Sciences.

[28]  S. Lloyd,et al.  Impact of High Glucose/High Insulin and Dichloroacetate Treatment on Carbohydrate Oxidation and Functional Recovery After Low-Flow Ischemia and Reperfusion in the Isolated Perfused Rat Heart , 2005, Circulation.

[29]  C. Wolf‐peeters,et al.  Protection of hepatocyte mitochondrial ultrastructure and function by strict blood glucose control with insulin in critically ill patients , 2005, The Lancet.

[30]  J. Lau,et al.  Insulin therapy for critically ill hospitalized patients: a meta-analysis of randomized controlled trials. , 2004, Archives of internal medicine.

[31]  P. O'Brien,et al.  The cytotoxic mechanism of glyoxal involves oxidative stress. , 2004, Biochemical pharmacology.

[32]  James Stephen Krinsley,et al.  Effect of an intensive glucose management protocol on the mortality of critically ill adult patients. , 2004, Mayo Clinic proceedings.

[33]  R. Bellomo,et al.  Acute renal failure – definition, outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group , 2004, Critical care.

[34]  Howard Cabral,et al.  Tight Glycemic Control in Diabetic Coronary Artery Bypass Graft Patients Improves Perioperative Outcomes and Decreases Recurrent Ischemic Events , 2004, Circulation.

[35]  Marco Novelli,et al.  Mitochondrial dysfunction in a long-term rodent model of sepsis and organ failure. , 2004, American journal of physiology. Regulatory, integrative and comparative physiology.

[36]  G. Van den Berghe,et al.  Metabolic, endocrine, and immune effects of stress hyperglycemia in a rabbit model of prolonged critical illness. , 2003, Endocrinology.

[37]  W. R. Bruce,et al.  Toxicity of glyoxals--role of oxidative stress, metabolic detoxification and thiamine deficiency. , 2003, Biochemical Society transactions.

[38]  Miet Schetz,et al.  Outcome benefit of intensive insulin therapy in the critically ill: Insulin dose versus glycemic control* , 2003, Critical care medicine.

[39]  M. Singer,et al.  Mitochondrial Dysfunction in Sepsis. , 1999, Current infectious disease reports.

[40]  John Land,et al.  Association between mitochondrial dysfunction and severity and outcome of septic shock , 2002, The Lancet.

[41]  V. Monnier,et al.  Alterations in renal mitochondrial respiration in response to the reactive oxoaldehyde methylglyoxal. , 2002, American journal of physiology. Renal physiology.

[42]  G. Van den Berghe,et al.  A novel in vivo rabbit model of hypercatabolic critical illness reveals a biphasic neuroendocrine stress response. , 2002, Endocrinology.

[43]  E. Crouser,et al.  Endotoxin-induced mitochondrial damage correlates with impaired respiratory activity , 2002, Critical care medicine.

[44]  M. Brownlee.  Biochemistry and molecular cell biology of diabetic complications , 2001, Nature.

[45]  E. L’her,et al.  A global approach to energy metabolism in an experimental model of sepsis. , 2001, American journal of respiratory and critical care medicine.

[46]  M Schetz,et al.  Intensive insulin therapy in critically ill patients. , 2001, The New England journal of medicine.

[47]  B. Szwergold,et al.  alpha-Dicarbonyls increase in the postprandial period and reflect the degree of hyperglycemia. , 2001, Diabetes care.

[48]  M. Fink.  Cytopathic hypoxia. Mitochondrial dysfunction as mechanism contributing to organ dysfunction in sepsis. , 2001, Critical care clinics.

[49]  P. Dorinsky,et al.  Ileal VO(2)-O(2) alterations induced by endotoxin correlate with severity of mitochondrial injury. , 1999, American journal of respiratory and critical care medicine.

[50]  L. Mascia,et al.  Acute renal failure in critically ill patients , 1999, Intensive Care Medicine.

[51]  J. Hibbert,et al.  Lactic acidosis during sepsis is related to increased pyruvate production, not deficits in tissue oxygen availability. , 1996, Annals of surgery.

[52]  M. Brezis,et al.  Physiology of Renal Hypoxia a , 1994, Annals of the New York Academy of Sciences.

[53]  P. Wouters,et al.  Measurement of organ blood flow with coloured microspheres: a first time-saving improvement using automated spectrophotometry , 1993, Proceedings of Computers in Cardiology Conference.

[54]  Paul J Thornalley,et al.  Sample Storage Conditions for the Assay of Glyoxalase Activities in Whole Blood Samples , 1992, Annals of clinical biochemistry.

[55]  Paul J Thornalley.  Modification of the glyoxalase system in human red blood cells by glucose in vitro. , 1988, The Biochemical journal.

[56]  G. Lobley,et al.  Energy and nitrogen metabolism of rabbits during pregnancy, lactation, and concurrent pregnancy and lactation , 1986, British Journal of Nutrition.

[57]  L. Miller,et al.  Efficacy of glucocorticoids in preventing mitochondrial metabolic failure in endotoxemia. , 1983, Circulatory shock.

[58]  H. Sies,et al.  Assay of glutathione, glutathione disulfide, and glutathione mixed disulfides in biological samples. , 1981, Methods in enzymology.

[59]  Y. Ogawa,et al.  Changes in adenine nucleotide and mitochondrial metabolism of the kidney of burned rats and their relation to insulin. , 1977, The Journal of laboratory and clinical medicine.

[60]  Hans Ulrich Bergmeyer,et al.  Methods of Enzymatic Analysis , 2019 .